Extended criteria increase organ donations without compromising patient health
Using more liberal criteria to evaluate potential lung donors combined with aggressive donor management significantly increases the availability of potential lung donors, and ultimately decreases mortality of recipients on the waiting list, says a new study presented at CHEST 2003, the 69th annual international scientific assembly of the American College of Chest Physicians (ACCP). The new study introduces the concept of physician-directed protocol (PDP), which incorporates the evaluation and management of every possible lung donor using more liberal or "extended" donor criteria and intensive education of pulmonologists and staff of the Organ Procurement Organization (OPO) in evaluating and managing donors with a set protocol. The study shows that with the use of this protocol, the number of lung donations increased by 119 percent and mean waiting time decreased by 70 percent. A related study also found that the use of lungs obtained from extended donors did not compromise the health of the organ recipient.
"The number of patients on the waiting list for lung transplants has continued to increase over the last several years, yet the number of donor lungs remains relatively stable. Therefore, the waiting time for a lung transplant has increased as has the number of patients who die while waiting for a transplant," said lead author Deborah Levine, MD, Assistant Professor in Medicine and Thoracic Surgery, University of Texas Health Science Center, San Antonio, TX. "A shortage of donor lungs is the primary limitation in increasing lung transplantation. With intensive education of the OPOs, we are now being called on every potential donor lung and evaluating them for the possibility of transplant."
Arielle Green | EurekAlert!
New discoveries predict ability to forecast dementia from single molecule
12.12.2018 | UT Southwestern Medical Center
Pain: Perception and motor impulses arise in the brain independently of one another
12.12.2018 | Technische Universität München
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
What if a sensor sensing a thing could be part of the thing itself? Rice University engineers believe they have a two-dimensional solution to do just that.
Rice engineers led by materials scientists Pulickel Ajayan and Jun Lou have developed a method to make atom-flat sensors that seamlessly integrate with devices...
Scientists at the University of Stuttgart and the Karlsruhe Institute of Technology (KIT) succeed in important further development on the way to quantum Computers.
Quantum computers one day should be able to solve certain computing problems much faster than a classical computer. One of the most promising approaches is...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
12.12.2018 | Health and Medicine
12.12.2018 | Physics and Astronomy
12.12.2018 | Health and Medicine